LifeMD, Inc.
LFMD
$4.27
-$0.40-8.57%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 193.06M | 178.28M | 163.56M | 152.55M | 135.81M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 193.06M | 178.28M | 163.56M | 152.55M | 135.81M |
| Cost of Revenue | 19.99M | 19.76M | 19.29M | 18.90M | 17.61M |
| Gross Profit | 173.06M | 158.52M | 144.28M | 133.65M | 118.19M |
| SG&A Expenses | 176.93M | 163.80M | 149.74M | 137.28M | 127.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 6.37M | 5.95M | 5.39M | 4.79M | 4.77M |
| Total Operating Expenses | 212.39M | 197.50M | 181.37M | 167.04M | 154.98M |
| Operating Income | -19.33M | -19.22M | -17.81M | -14.49M | -19.18M |
| Income Before Tax | -21.52M | -21.56M | -20.62M | -17.41M | -25.83M |
| Income Tax Expenses | 660.50K | 428.00K | 428.00K | 428.00K | 360.70K |
| Earnings from Continuing Operations | -22.19 | -21.99 | -21.05 | -17.84 | -26.19 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -322.10K | -1.51M | -2.31M | -2.76M | -2.61M |
| Net Income | -22.51M | -23.50M | -23.36M | -20.60M | -28.80M |
| EBIT | -19.33M | -19.22M | -17.81M | -14.49M | -19.18M |
| EBITDA | -17.98M | -17.97M | -16.61M | -13.32M | -18.00M |
| EPS Basic | -0.64 | -0.70 | -0.75 | -0.70 | -0.99 |
| Normalized Basic EPS | -0.34 | -0.39 | -0.43 | -0.40 | -0.50 |
| EPS Diluted | -0.65 | -0.71 | -0.75 | -0.71 | -0.99 |
| Normalized Diluted EPS | -0.34 | -0.39 | -0.43 | -0.40 | -0.50 |
| Average Basic Shares Outstanding | 159.30M | 151.75M | 143.02M | 135.46M | 130.13M |
| Average Diluted Shares Outstanding | 159.30M | 151.75M | 143.02M | 135.46M | 130.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -13.80% | -13.22% | -13.30% | -15.08% | -10.79% |
